Biotechnology Bulletin ›› 2020, Vol. 36 ›› Issue (10): 165-172.doi: 10.13560/j.cnki.biotech.bull.1985.2020-0012

Previous Articles     Next Articles

Functional Analysis and Validation of Mg2+ Binding Sites of Intron-encoded Protein

CUI Gu-zhen1,3(), CHEN Xiang-hao2, HONG Wei4, ZHANG Zheng-rong1,3, QI Ting-na1,3, CHEN Zheng-hong1,3()   

  1. 1. School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550025
    2. The Third Affiliated Hospital of Zunyi Medical Univesity(The First People’s Hospital of Zunyi),Zunyi 563002
    3. Key Laboratory of Medical Microbiology and Parasitology of Education Department of Guizhou,Guiyang 550025
    4. Key Laboratory of Molecular Biology of Guizhou,Guizhou Medical University,Guiyang 550004
  • Received:2020-01-03 Online:2020-10-26 Published:2020-11-02
  • Contact: CHEN Zheng-hong E-mail:cuiguzhen@gmc.edu.cn;chenzhenghong@gmc.edu.cn

Abstract:

This work aims to screen and construct the mutants of having intron-encoded protein Mg2+ binding site,and to verify its effect on the “Retrohoming” efficiency of group II intron. Bioinformatics technology was used to screen key sites,site-directed mutation technology to construct mutants,and Targetron and blue-and-white spot counting methods to verify its “Retrohoming” efficiency. Results showed that 2 sites,D308 and D309,were identified as the core catalytic sites for group II intron-encoded protein Mg 2+ binding,and three mutants of these sites were successfully constructed,including two single-site mutants(D308A and D309A)and a double-site mutant(D308A/D309A). The experimental results in Escherichia coli showed that all three mutants completely inactivated the “Retrohoming” function of group II intron. In conclusion,this work confirms that the Mg 2+ binding sites of group II intron-encoded protein is the core catalytic site of it playing function.

Key words: group II introns, intron-encoded protein, Mg2+ binding sites, Targetron, reverse transcription domain